Clinical trial / 2014
Docosahexaenoic acid supplementation did not improve core autism symptoms in children.
A randomized trial assigned 48 children aged 3 to 10 years with autism to receive 200 mg daily of DHA or placebo for 6 months. Despite a median 431% surge in total plasma DHA, core autism symptoms on the Clinical Global Impressions-Improvement scale did not differ between cohorts. Parents reported superior social skills in the placebo group (P = 0.04), whereas teachers reported better functional communication with DHA (P = 0.02).
- Study type
- Randomized controlled trial
- Who was studied
- 48 children aged 3-10 with autism
- What was measured
- Core autism symptoms, behavioral ratings, and plasma DHA levels
THE PAPER
Dietary docosahexaenoic acid supplementation in children with autism.
Voigt RG, Mellon MW, Katusic SK, Weaver AL, Matern D, Mellon B, Jensen CL, Barbaresi WJ. J Pediatr Gastroenterol Nutr, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.